Brief: Alligator Bioscience Q2 EBIT SEK -36.2 Million
26/08/2026 07:02
BRIEF-Alligator Bioscience Q2 EBIT SEK -36.2 Million Aug 26 (Reuters) - Alligator Bioscience Q2 adjusted EPS SEK -0.06.
- Q2 net income SEK -37.8 million
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue